Best Practices for GLP-1 Injection Sites Regardless of the chosen site, adhering to best practices for administering injections is key to maximizing the benefits of GLP-1 therapy
Efficacy of metabolic and bariatric surgery compared with GLP-1 receptor agonist treatment in preventing mortality and major adverse cardiac events among individuals with obesity and type 2 diabetes: A systematic review and meta-analysis
Your doctor should know if you have a history of: Pancreatitis (acute or chronic)both medications carry warnings about pancreatitis risk Severe gastrointestinal disease , including gastroparesis, which may be exacerbated by GLP-1-based therapies Renal impairment sitagliptin requires dose adjustment based on eGFR, while tirzepatide does not require dose adjustment, though caution is advised with dehydration Thyroid disease Mounjaro's UK SmPC notes that rodent studies showed an increased incidence of thyroid C-cell tumours, though the relevance to humans is unknown
2,5,8-10,12,13 As research advances, these insights highlight the potential of nutrition science to inform future GLP-1-targeted therapies and sustainable strategies for metabolic health